Cipher Pharmaceuticals Inc. ("Cipher" or the "Company") today announced that Health Canada has accepted for review Cipher's new drug submission ("NDS") for Natrobatm (Spinosad), for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results